[HTML][HTML] ABC transporter superfamily. An updated overview, relevance in cancer multidrug resistance and perspectives with personalized medicine

PDM Juan-Carlos, PP Perla-Lidia… - Molecular biology …, 2021 - Springer
The ATP binding-cassette superfamily corresponds the mostly transmembrane transporters
family found in humans. These proteins actively transport endogenous and exogenous …

[HTML][HTML] Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years

M Panczyk - World Journal of Gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
During the past two decades the first sequencing of the human genome was performed
showing its high degree of inter-individual differentiation, as a result of large international …

Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1-and ABCG2-overexpressing cancer cells

N Ji, Y Yang, CY Cai, ZN Lei, JQ Wang, P Gupta… - Cancer letters, 2019 - Elsevier
Overexpression of ATP-binding cassette (ABC) transporters is one of the most important
mechanisms responsible for the development of multidrug resistance (MDR). Selonsertib, a …

[HTML][HTML] Effect of ABC transporter expression and mutational status on survival rates of cancer patients

O Kadioglu, MEM Saeed, M Munder, A Spuller… - Biomedicine & …, 2020 - Elsevier
ATP-binding cassette (ABC) transporters mediate multidrug resistance in cancer. In contrast
to DNA single nucleotide polymorphisms in normal tissues, the role of mutations in tumors is …

[HTML][HTML] FOLFOX/FOLFIRI pharmacogenetics: the call for a personalized approach in colorectal cancer therapy

B Mohelnikova-Duchonova, B Melichar… - World journal of …, 2014 - ncbi.nlm.nih.gov
While 5-fluorouracil used as single agent in patients with metastatic colorectal cancer has an
objective response rate around 20%, the administration of combinations of irinotecan with 5 …

Pharmacogenomics of intrinsic and acquired pharmacoresistance in colorectal cancer: toward targeted personalized therapy

E De Mattia, E Cecchin, G Toffoli - Drug Resistance Updates, 2015 - Elsevier
Colorectal cancer (CRC) represents one of the most common malignancies and is major
cause of cancer-related deaths worldwide. A great improvement in response rate and …

[HTML][HTML] A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage

JM Findlay, MR Middleton, I Tomlinson - Annals of Oncology, 2015 - Elsevier
Recent advances in next generation sequencing reinforce the potential for DNA sequence
markers to guide esophageal cancer management. We report the first systematic review and …

[HTML][HTML] Midostaurin Reverses ABCB1-Mediated Multidrug Resistance, an in vitro Study

N Ji, Y Yang, CY Cai, JQ Wang, ZN Lei, ZX Wu… - Frontiers in …, 2019 - frontiersin.org
Overexpression of ABC transporters in cancer cells is an underlying mechanism of multidrug
resistance (MDR), leading to insensitive response to chemotherapeutic strategies. Thus …

Role of ABC transporters in fluoropyrimidine-based chemotherapy response

AT Nies, T Magdy, M Schwab, UM Zanger - Advances in cancer research, 2015 - Elsevier
Abstract Since over 50 years, 5-fluorouracil (5-FU) is in use as backbone of chemotherapy
treatment regimens for a wide range of cancers including colon, breast, and head and neck …

Genetic variants as potential predictive biomarkers in advanced colorectal cancer patients treated with oxaliplatin‐based chemotherapy

A Bahrami, F Amerizadeh… - Journal of cellular …, 2018 - Wiley Online Library
Chemotherapy regimen containing oxaliplatin is often the first‐line treatment for patient with
advanced colorectal cancer. Oxaliplatin binds to DNA, leading to the formation of crosslinks …